LIGAND PHARMACEUTICALS INCORPORATED
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $1.26B
Liabilities Breakdown FY2018
Total Liabilities: $699.9M
Asset Breakdown
Total Assets: $1.26B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $117.2M | 9.3% |
| Accounts Receivable | $55.9M | 4.4% |
| Inventory | $7.1M | 0.6% |
| Property, Plant & Equipment | $5.4M | 0.4% |
| Goodwill | $86.6M | 6.9% |
| Intangible Assets | $219.8M | 17.4% |
| Other Assets | $768.9M | 61.0% |
Liabilities Breakdown
Total Liabilities: $699.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.2M | 0.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $695.7M | 99.4% |